ArticleFrontiers in pharmacology2024

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma.

Yue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.